These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
844 related articles for article (PubMed ID: 25168354)
1. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma. van de Nes JA; Griewank KG; Schmid KW; Grabellus F Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354 [TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade. Mahzouni P; Movahedipour M Pathol Res Pract; 2012 Apr; 208(4):221-4. PubMed ID: 22420924 [TBL] [Abstract][Full Text] [Related]
3. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas. Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568 [TBL] [Abstract][Full Text] [Related]
4. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661 [TBL] [Abstract][Full Text] [Related]
5. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival. Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286 [TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709 [TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography elucidates transport system and tumor proliferation in meningiomas. Murakami M; Imahori Y; Kimura S; Tatsuzawa K; Ohwada K; Inoue Y; Sasajima H; Mineura K Oncol Rep; 2005 Oct; 14(4):853-9. PubMed ID: 16142342 [TBL] [Abstract][Full Text] [Related]
8. Comparative proteomic profiles of meningioma subtypes. Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085 [TBL] [Abstract][Full Text] [Related]
9. Osteopontin predicts the behaviour of atypical meningioma. Lin CK; Tsai WC; Lin YC; Hueng DY Histopathology; 2012 Jan; 60(2):320-5. PubMed ID: 22211290 [TBL] [Abstract][Full Text] [Related]
10. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas. Lee SH; Lee YS; Hong YG; Kang CS APMIS; 2014 Jan; 122(1):16-24. PubMed ID: 23756256 [TBL] [Abstract][Full Text] [Related]
11. The expression of hypoxia-inducible factor-1 in primary brain tumors. Reszec J; Rutkowski R; Chyczewski L Int J Neurosci; 2013 Sep; 123(9):657-62. PubMed ID: 23550771 [TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin and catenins in meningioma: ubiquitous expression and its irrelevance to malignancy. Shimada S; Ishizawa K; Hirose T Pathol Int; 2005 Jan; 55(1):1-7. PubMed ID: 15660696 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227 [TBL] [Abstract][Full Text] [Related]
14. Expression of GLUT3 and HIF-1 Mei T; Wang Z; Wu J; Liu X; Tao W; Wang S; Chen F Biomed Res Int; 2020; 2020():1682352. PubMed ID: 32908869 [TBL] [Abstract][Full Text] [Related]
15. WHO grade related expression of TRAIL-receptors and apoptosis regulators in meningioma. Koschny R; Krupp W; Xu LX; Mueller WC; Bauer M; Sinn P; Keller M; Koschny T; Walczak H; Bruckner T; Ganten TM; Holland H Pathol Res Pract; 2015 Feb; 211(2):109-16. PubMed ID: 25481563 [TBL] [Abstract][Full Text] [Related]
16. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma. Shayanfar N; Mashayekh M; Mohammadpour M Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648 [TBL] [Abstract][Full Text] [Related]
17. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema. Nassehi D Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727 [TBL] [Abstract][Full Text] [Related]
18. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326 [TBL] [Abstract][Full Text] [Related]
19. Comparative study of soft tissue perineurioma and meningioma using a five-marker immunohistochemical panel. Agaimy A; Buslei R; Coras R; Rubin BP; Mentzel T Histopathology; 2014 Jul; 65(1):60-70. PubMed ID: 24393170 [TBL] [Abstract][Full Text] [Related]
20. Correlation of p63 protein expression with histological grade of meningiomas: an immunohistochemical study. Mittal S; Jain D; Roy S; Mehta VS Int J Surg Pathol; 2012 Aug; 20(4):349-54. PubMed ID: 22287651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]